Efficacy and potential use of vitamin D in the prevention and treatment of uterine fibroids
DOI:
https://doi.org/10.12775/JEHS.2023.45.01.007Keywords
uterine fibroids, vitamin D, uterine leiomyomas, vitamin D deficiency, fibroidsAbstract
Introduction: Uterine fibroids (UFs) are the most common benign gynecological tumors. Pharmacological and/or surgical treatments are frequently required, depending on the woman's desire to preserve fertility. Due to side effects caused by pharmacological and surgical treatments, there is a growing interest in a safe approach for UFs. In recent years, hypovitaminosis D is believed to be a major risk factor in the development of a tumor. Studies proved vitamin D efficacy in inhibiting UFs growth by targeting pathways involved in the regulation of various biological processes, resulting in inhibition of tumor cell division and a significant reduction in its size. Vitamin D seems to be promising, effective, and low-cost method in the management of UFs and their clinical symptoms.
Aim of the study: This article reviews the state of knowledge based on available studies. The aim of the study is to present the most important informations about effectiveness and potential usage of vitamin D in prevention and treatment of uterine fibroids.
Material and methods: The authors created a paper summarizing review of currently available publications based on databases such as PubMed, Scopus and Google Scholar.
References
Chen R, You J. Comparison of hysterectomy and uterine artery embolization in the treatment of symptomatic uterine fibroids: A protocol for systematic review and meta-analysis. Medicine (Baltimore). 2022 Dec 30;101(52):e32440. doi: 10.1097/MD.0000000000032440. PMID: 36596045; PMCID: PMC9803433.
Giuliani E, As-Sanie S, Marsh EE. Epidemiology and management of uterine fibroids. Int J Gynaecol Obstet. 2020 Apr;149(1):3-9. doi: 10.1002/ijgo.13102. Epub 2020 Feb 17. PMID: 31960950.
Al-Hendy A, Myers ER, Stewart E. Uterine Fibroids: Burden and Unmet Medical Need. Semin Reprod Med. 2017 Nov;35(6):473-480. doi: 10.1055/s-0037-1607264. Epub 2017 Nov 3. PMID: 29100234; PMCID: PMC6193285.
Bartels CB, Cayton KC, Chuong FS, Holthouser K, Arian SE, Abraham T, Segars JH. An Evidence-based Approach to the Medical Management of Fibroids: A Systematic Review. Clin Obstet Gynecol. 2016 Mar;59(1):30-52. doi: 10.1097/GRF.0000000000000171. PMID: 26756261.
Pavone D, Clemenza S, Sorbi F, Fambrini M, Petraglia F. Epidemiology and Risk Factors of Uterine Fibroids. Best Pract Res Clin Obstet Gynaecol. 2018 Jan;46:3-11. doi: 10.1016/j.bpobgyn.2017.09.004. Epub 2017 Oct 1. PMID: 29054502.
Markowska A, Kurzawa P, Bednarek W, Gryboś A, Mardas M, Krzyżaniak M, Majewski J, Markowska J, Gryboś M, Żurawski J. Immunohistochemical Expression of Vitamin D Receptor in Uterine Fibroids. Nutrients. 2022 Aug 17;14(16):3371. doi: 10.3390/nu14163371. PMID: 36014877; PMCID: PMC9415784.
Bulun SE. Uterine fibroids. N Engl J Med. 2013 Oct 3;369(14):1344-55. doi: 10.1056/NEJMra1209993. PMID: 24088094.
Islam MS, Protic O, Stortoni P, Grechi G, Lamanna P, Petraglia F, Castellucci M, Ciarmela P. Complex networks of multiple factors in the pathogenesis of uterine leiomyoma. Fertil Steril. 2013 Jul;100(1):178-93. doi: 10.1016/j.fertnstert.2013.03.007. Epub 2013 Apr 1. PMID: 23557758.
Chill HH, Safrai M, Reuveni Salzman A, Shushan A. The Rising Phoenix-Progesterone as the Main Target of the Medical Therapy for Leiomyoma. Biomed Res Int. 2017;2017:4705164. doi: 10.1155/2017/4705164. Epub 2017 Sep 13. PMID: 29312996; PMCID: PMC5615958.
Reis FM, Bloise E, Ortiga-Carvalho TM. Hormones and pathogenesis of uterine fibroids. Best Pract Res Clin Obstet Gynaecol. 2016 Jul;34:13-24. doi: 10.1016/j.bpobgyn.2015.11.015. Epub 2015 Nov 25. PMID: 26725037.
Ciebiera M, Włodarczyk M, Zgliczyńska M, Łukaszuk K, Męczekalski B, Kobierzycki C, Łoziński T, Jakiel G. The Role of Tumor Necrosis Factor α in the Biology of Uterine Fibroids and the Related Symptoms. Int J Mol Sci. 2018 Dec 4;19(12):3869. doi: 10.3390/ijms19123869. PMID: 30518097; PMCID: PMC6321234.
Al-Hendy A, Laknaur A, Diamond MP, Ismail N, Boyer TG, Halder SK. Silencing Med12 Gene Reduces Proliferation of Human Leiomyoma Cells Mediated via Wnt/β-Catenin Signaling Pathway. Endocrinology. 2017 Mar 1;158(3):592-603. doi: 10.1210/en.2016-1097. PMID: 27967206; PMCID: PMC5460776.
Sparic R, Mirkovic L, Malvasi A, Tinelli A. Epidemiology of Uterine Myomas: A Review. Int J Fertil Steril. 2016 Jan-Mar;9(4):424-35. doi: 10.22074/ijfs.2015.4599. Epub 2015 Dec 23. PMID: 26985330; PMCID: PMC4793163.
Ciebiera M, Włodarczyk M, Zgliczyński S, Łoziński T, Walczak K, Czekierdowski A. The Role of miRNA and Related Pathways in Pathophysiology of Uterine Fibroids-From Bench to Bedside. Int J Mol Sci. 2020 Apr 24;21(8):3016. doi: 10.3390/ijms21083016. PMID: 32344726; PMCID: PMC7216240.
Cardozo ER, Foster R, Karmon AE, Lee AE, Gatune LW, Rueda BR, Styer AK. MicroRNA 21a-5p overexpression impacts mediators of extracellular matrix formation in uterine leiomyoma. Reprod Biol Endocrinol. 2018 May 11;16(1):46. doi: 10.1186/s12958-018-0364-8. PMID: 29747655; PMCID: PMC5946472.
Brakta S, Diamond JS, Al-Hendy A, Diamond MP, Halder SK. Role of vitamin D in uterine fibroid biology. Fertil Steril. 2015 Sep;104(3):698-706. doi: 10.1016/j.fertnstert.2015.05.031. Epub 2015 Jun 13. PMID: 26079694; PMCID: PMC4561014.
Donnez J, Dolmans MM. Uterine fibroid management: from the present to the future. Hum Reprod Update. 2016 Nov;22(6):665-686. doi: 10.1093/humupd/dmw023. Epub 2016 Jul 27. PMID: 27466209; PMCID: PMC5853598.
Golan A. GnRH analogues in the treatment of uterine fibroids. Hum Reprod. 1996 Nov;11 Suppl 3:33-41. doi: 10.1093/humrep/11.suppl_3.33. PMID: 9147100.
Donnez J, Tatarchuk TF, Bouchard P, Puscasiu L, Zakharenko NF, Ivanova T, Ugocsai G, Mara M, Jilla MP, Bestel E, Terrill P, Osterloh I, Loumaye E; PEARL I Study Group. Ulipristal acetate versus placebo for fibroid treatment before surgery. N Engl J Med. 2012 Feb 2;366(5):409-20. doi: 10.1056/NEJMoa1103182. PMID: 22296075.
Bhave Chittawar P, Franik S, Pouwer AW, Farquhar C. Minimally invasive surgical techniques versus open myomectomy for uterine fibroids. Cochrane Database Syst Rev. 2014 Oct 21;(10):CD004638. doi: 10.1002/14651858.CD004638.pub3. PMID: 25331441.
Emanuel MH, Wamsteker K, Hart AA, Metz G, Lammes FB. Long-term results of hysteroscopic myomectomy for abnormal uterine bleeding. Obstet Gynecol. 1999 May;93(5 Pt 1):743-8. doi: 10.1016/s0029-7844(98)00558-4. PMID: 10912978.
Gupta JK, Sinha A, Lumsden MA, Hickey M. Uterine artery embolization for symptomatic uterine fibroids. Cochrane Database Syst Rev. 2014 Dec 26;(12):CD005073. doi: 10.1002/14651858.CD005073.pub4. PMID: 25541260.
Brązert M., Korman M., Pawelczyk L. Zastosowanie selektywnych modulatorów receptora progesteronowego w leczeniu mięśniaków macicy oraz ich przyszłość w ginekologii. Ginekol Pol. 2013; 84(9), 794-800.
Skowrońska P, Pastuszek E, Kuczyński W, Jaszczoł M, Kuć P, Jakiel G, Wocławek-Potocka I, Łukaszuk K. The role of vitamin D in reproductive dysfunction in women - a systematic review. Ann Agric Environ Med. 2016 Dec 23;23(4):671-676. doi: 10.5604/12321966.1226865. PMID: 28030942.
Haines ST, Park SK. Vitamin D supplementation: what's known, what to do, and what's needed. Pharmacotherapy. 2012 Apr;32(4):354-82. doi: 10.1002/phar.1037. PMID: 22461123.
Vergara D, Catherino WH, Trojano G, Tinelli A. Vitamin D: Mechanism of Action and Biological Effects in Uterine Fibroids. Nutrients. 2021 Feb 11;13(2):597. doi: 10.3390/nu13020597. PMID: 33670322; PMCID: PMC7917888.
Carlberg C, Muñoz A. An update on vitamin D signaling and cancer. Semin Cancer Biol. 2022 Feb;79:217-230. doi: 10.1016/j.semcancer.2020.05.018. Epub 2020 May 30. PMID: 32485310.
Dabrowski FA, Grzechocinska B, Wielgos M. The role of vitamin D in reproductive health--a Trojan Horse or the Golden Fleece? Nutrients. 2015 May 29;7(6):4139-53. doi: 10.3390/nu7064139. PMID: 26035242; PMCID: PMC4488777.
Nesby-O'Dell S, Scanlon KS, Cogswell ME, Gillespie C, Hollis BW, Looker AC, Allen C, Doughertly C, Gunter EW, Bowman BA. Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: third National Health and Nutrition Examination Survey, 1988-1994. Am J Clin Nutr. 2002 Jul;76(1):187-92. doi: 10.1093/ajcn/76.1.187. PMID: 12081833.
Płudowski P, Kos-Kudła B, Walczak M, Fal A, Zozulińska-Ziółkiewicz D, Sieroszewski P, Peregud-Pogorzelski J, Lauterbach R, Targowski T, Lewiński A, Spaczyński R, Wielgoś M, Pinkas J, Jackowska T, Helwich E, Mazur A, Ruchała M, Zygmunt A, Szalecki M, Bossowski A, Czech-Kowalska J, Wójcik M, Pyrżak B, Żmijewski MA, Abramowicz P, Konstantynowicz J, Marcinowska-Suchowierska E, Bleizgys A, Karras SN, Grant WB, Carlberg C, Pilz S, Holick MF, Misiorowski W. Guidelines for Preventing and Treating Vitamin D Deficiency: A 2023 Update in Poland. Nutrients. 2023 Jan 30;15(3):695. doi: 10.3390/nu15030695. PMID: 36771403; PMCID: PMC9920487.
Sabry M, Halder SK, Allah AS, Roshdy E, Rajaratnam V, Al-Hendy A. Serum vitamin D3 level inversely correlates with uterine fibroid volume in different ethnic groups: a cross-sectional observational study. Int J Womens Health. 2013;5:93-100. doi: 10.2147/IJWH.S38800. Epub 2013 Feb 27. PMID: 23467803; PMCID: PMC3589082.
Paffoni A, Somigliana E, Vigano' P, Benaglia L, Cardellicchio L, Pagliardini L, Papaleo E, Candiani M, Fedele L. Vitamin D status in women with uterine leiomyomas. J Clin Endocrinol Metab. 2013 Aug;98(8):E1374-8. doi: 10.1210/jc.2013-1777. Epub 2013 Jul 3. PMID: 23824422.
Baird DD, Hill MC, Schectman JM, Hollis BW. Vitamin d and the risk of uterine fibroids. Epidemiology. 2013 May;24(3):447-53. doi: 10.1097/EDE.0b013e31828acca0. PMID: 23493030; PMCID: PMC5330388.
Mitro SD, Zota AR. Vitamin D and uterine leiomyoma among a sample of US women: Findings from NHANES, 2001-2006. Reprod Toxicol. 2015 Nov;57:81-6. doi: 10.1016/j.reprotox.2015.05.013. Epub 2015 Jun 3. PMID: 26047529; PMCID: PMC4550549.
Ciebiera M, Włodarczyk M, Słabuszewska-Jóźwiak A, Nowicka G, Jakiel G. Influence of vitamin D and transforming growth factor β3 serum concentrations, obesity, and family history on the risk for uterine fibroids. Fertil Steril. 2016 Dec;106(7):1787-1792. doi: 10.1016/j.fertnstert.2016.09.007. Epub 2016 Oct 12. PMID: 27743697.
Singh V, Barik A, Imam N. Vitamin D3 Level in Women with Uterine Fibroid: An Observational Study in Eastern Indian Population. J Obstet Gynaecol India. 2019 Apr;69(2):161-165. doi: 10.1007/s13224-018-1195-4. Epub 2018 Dec 6. PMID: 30956471; PMCID: PMC6430262.
Srivastava P, Gupta HP, Singhi S, Khanduri S, Rathore B. Evaluation of 25-hydroxy vitamin D3 levels in patients with a fibroid uterus. J Obstet Gynaecol. 2020 Jul;40(5):710-714. doi: 10.1080/01443615.2019.1654986. Epub 2019 Oct 22. PMID: 31635506.
Li S, Chen B, Sheng B, Wang J, Zhu X. The associations between serum vitamin D, calcium and uterine fibroids in Chinese women: a case-controlled study. J Int Med Res. 2020 May;48(5):300060520923492. doi: 10.1177/0300060520923492. PMID: 32458705; PMCID: PMC7273764.
Ciavattini A, Delli Carpini G, Serri M, Vignini A, Sabbatinelli J, Tozzi A, Aggiusti A, Clemente N. Hypovitaminosis D and "small burden" uterine fibroids: Opportunity for a vitamin D supplementation. Medicine (Baltimore). 2016 Dec;95(52):e5698. doi: 10.1097/MD.0000000000005698. PMID: 28033263; PMCID: PMC5207559.
Hajhashemi M, Ansari M, Haghollahi F, Eslami B. The effect of vitamin D supplementation on the size of uterine leiomyoma in women with vitamin D deficiency. Caspian J Intern Med. 2019 Spring;10(2):125-131. doi: 10.22088/cjim.10.2.125. PMID: 31363390; PMCID: PMC6619469.
Arjeh S, Darsareh F, Asl ZA, Azizi Kutenaei M. Effect of oral consumption of vitamin D on uterine fibroids: A randomized clinical trial. Complement Ther Clin Pract. 2020 May;39:101159. doi: 10.1016/j.ctcp.2020.101159. Epub 2020 Apr 2. PMID: 32379687.
Baird DD, Hill MC, Schectman JM, Hollis BW. Vitamin d and the risk of uterine fibroids. Epidemiology. 2013 May;24(3):447-53. doi: 10.1097/EDE.0b013e31828acca0. PMID: 23493030; PMCID: PMC5330388.
Halder SK, Osteen KG, Al-Hendy A. Vitamin D3 inhibits expression and activities of matrix metalloproteinase-2 and -9 in human uterine fibroid cells. Hum Reprod. 2013 Sep;28(9):2407-16. doi: 10.1093/humrep/det265. Epub 2013 Jun 27. PMID: 23814095; PMCID: PMC3748859.
Halder SK, Osteen KG, Al-Hendy A. 1,25-dihydroxyvitamin d3 reduces extracellular matrix-associated protein expression in human uterine fibroid cells. Biol Reprod. 2013 Dec 26;89(6):150. doi: 10.1095/biolreprod.113.107714. PMID: 24174578; PMCID: PMC4076359.
Ciebiera M, Włodarczyk M, Wrzosek M, Męczekalski B, Nowicka G, Łukaszuk K, Ciebiera M, Słabuszewska-Jóźwiak A, Jakiel G. Role of Transforming Growth Factor β in Uterine Fibroid Biology. Int J Mol Sci. 2017 Nov 17;18(11):2435. doi: 10.3390/ijms18112435. PMID: 29149020; PMCID: PMC5713402.
Corachán A, Trejo MG, Carbajo-García MC, Monleón J, Escrig J, Faus A, Pellicer A, Cervelló I, Ferrero H. Vitamin D as an effective treatment in human uterine leiomyomas independent of mediator complex subunit 12 mutation. Fertil Steril. 2021 Feb;115(2):512-521. doi: 10.1016/j.fertnstert.2020.07.049. Epub 2020 Oct 7. PMID: 33036796.
Al-Hendy A, Diamond MP, El-Sohemy A, Halder SK. 1,25-dihydroxyvitamin D3 regulates expression of sex steroid receptors in human uterine fibroid cells. J Clin Endocrinol Metab. 2015 Apr;100(4):E572-82. doi: 10.1210/jc.2014-4011. Epub 2015 Jan 27. PMID: 25625804; PMCID: PMC4399292.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Martyna Kozłowska, Aleksander Woźniak, Patryk Sydor, Marcel Wartacz, Mateusz Góra, Rafał Kreft, Adrian Krzysztof Hunek, Anna Maria Bigdoń, Maciej Ćwiek, Przemysław Gorczyca
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 309
Number of citations: 0